Learning data-driven patient risk stratification models for Clostridium difficile

Open Forum Infectious Diseases

Volumn 1, Issue 2, 2014, Pages

  Wiens, Jenna ^a   Campbell, Wayne N ^b   Franklin, Ella S ^c   Guttag, John V ^a   Horvitz, Eric ^d  

^a Department of Electrical Engineering and Computer Science   (United States)

^b UNION MEMORIAL HOSPITAL   (United States)

^c MEDSTAR HEALTH   (United States)

^d MICROSOFT RESEARCH   (United States)

Author keywords

Clostridium difficile; Data driven methods; Electronic medical records; Machine learning; Risk stratification

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD REVIEW; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; VERY ELDERLY;

EID: 84952015331     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu045     Document Type: Article

References (28)

1. Boone J, Goodykoontz M, Rhodes S, et al. Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis 2012; 31:1551-9.
2. National Hospital Discharge Survey. Annual Files, 1996-2009.
3. Ghantoji S, Sail K, Lairson D, et al. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010; 74:309-18.
4. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
5. Larson EL, Cohen B, Ross B, Behta M. Isolation precautions for methicillin- resistant Staphylococcus aureus: electronic surveillance to monitor adherence. Am J Crit Care 2010; 19:16-26.
6. Dubberke ER, Reske KA, Yan Y, et al. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45:1543-9.
7. Garey K, Dao-Tran T, Jiang Z, et al. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect 2008; 70:142-7.
8. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile- associated enteric disease. Ann Intern Med 2006; 145:758-64.
9. Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012; 157:878-88.
10. Leekha S, Aronhalt KC, Sloan LM, et al. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control 2013; 41:390-3.
11. Garey K, Sethi S, Yadav Y, DuPont H. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008; 70:298-304.
12. Kurd MF, Pulido L, Joshi A, et al. Clostridium difficile infection after total joint arthroplasty: who is at risk? J Arthroplasty 2008; 23:839-42.
13. Drekonja DM, Amundson WH, DeCarolis DD, et al. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 2011; 124:1081.e1-e7.
14. Lee JH, Lee SY, Kim YS, et al. The incidence and clinical features of Clostridium difficile infection: single center study. Korean J Gastroenterol 2010; 55:175-82.
15. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficileassociated diarrhea and proton pump inhibitor therapy: a metaanalysis. Am J Gastroenterol 2012; 107:1001-10.
16. Bliss DZ, Johnson S, Savik K, et al. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998; 129:1012-9.
17. Linsky A, Gupta K, Lawler EV, et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010; 170:772.
18. Tsiouris A, Neale JA, Reickert CA, Times M. Clostridium difficile of the ileum following total abdominal colectomy, with or without proctectomy: who is at risk? Dis Colon Rectum 2012; 55:424-8.
19. O'Keefe SJ. Tube feeding, the microbiota, and Clostridium difficile infection. World J Gastroenterol 2010; 16:139.
20. Deshpande A, Pasupuleti V, Thota P, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68:1951-61.
21. Le Cessie S, Van Houwelingen J. Ridge estimators in logistic regression. Appl Stat 1992; 41:191-201.
22. Tanner J, Khan D, Anthony D, Paton J. Waterlow score to predict patients at risk of developing Clostridium difficile-associated disease. J Hosp Infect 2009; 71:239-44.
23. Dubberke ER, Yan Y, Reske KA, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011; 32:360.
24. Krapohl GL. Preventing health care-associated infection: development of a clinical prediction rule for Clostridium difficile Infection. University of Michigan, 2011.
25. Centers for Disease Control and Prevention. Multidrug-Resistant Organism & Clostridium difficile Infection (MDRO/CDI) Module January 2014.
26. Yokoe DS, Classen D. Improving patient safety through infection control: a new healthcare imperative. Infect Control Hosp Epidemiol 2008; 29(S1):S3-11.
27. Carrico R. APIC Implementation Guide: Guide to Preventing Clostridium difficile Infections. Washington: Published by the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC). 2013.
28. Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32:201-6.